Status:
COMPLETED
Profile of Depressive Symptoms in Parkinsons Disease
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Parkinson Disease
Depression
Eligibility:
All Genders
18+ years
Brief Summary
To explore or establish the relationship between cognitive, mood and motor symptoms in PD to scores on depression rating scales in a naturalistic setting.
Eligibility Criteria
Inclusion
- Inclusion\_Criteria:
- Observation criteria:
- are able to provide written informed consent in accordance with Good Clinical Practice (GCP) and local legislation
- have idiopathic Parkinsons disease according to the United Kingdom Parkinsons Disease Society Brain Bank Diagnostic Criteria for Parkinsons disease
- show no impairment of cognitive function (MMSE score ?24)
- are with or without symptoms of depression (full range)
- are stable on anti-Parkinson/anti-depressive treatment for at least 1 month before entering the study
- are or are not on concomitant antidepressant treatment
- are in the on state during the observation period
- did not previously undergo PD surgery
Exclusion
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
End Date :
October 1 2006
Estimated Enrollment :
1018 Patients enrolled
Trial Details
Trial ID
NCT00349310
Start Date
April 1 2006
End Date
October 1 2006
Last Update
December 14 2023
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site
Innsbruck, Austria, 6020
2
Boehringer Ingelheim Investigational Site
Vienna, Austria, 1090
3
Boehringer Ingelheim Investigational Site
Vienna, Austria, 1130
4
Hopital Rangueil
Toulouse, France, 31059